Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 13, 2026
Total Value: $347M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNTH | DIANTHUS THERAPEUTICS INC | 2,104,184 | $86.71M | 25.0% | $21.50 | +80.3% | COM | 252828108 |
| CGON | CG ONCOLOGY INC | 1,472,699 | $61.15M | 17.6% | $33.90 | +22.1% | COM | 156944100 |
| JBIO | JADE BIOSCIENCES INC | 1,400,708 | $21.61M | 6.2% | $29.10 | -59.7% | COM NEW | 008064206 |
| ORKA | ORUKA THERAPEUTICS INC | 660,424 | $20.02M | 5.8% | $25.47 | +9.4% | COM | 687604108 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 417,300 | $13.02M | 3.8% | $15.79 | — | SPONSORED ADS | 881624209 |
| BSX | BOSTON SCIENTIFIC CORP | 114,500 | $10.92M | 3.1% | $49.10 | +99.7% | COM | 101137107 |
| MDT | MEDTRONIC PLC | 107,600 | $10.34M | 3.0% | $91.27 | +6.4% | SHS | G5960L103 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 3,210,733 | $8.83M | 2.5% | $9.77 | -70.8% | COM NEW | 46489V302 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 21,000 | $8.351M | 2.4% | $442.56 | 0.0% | COM | 02043Q107 |
| RGEN | REPLIGEN CORP | 50,300 | $8.242M | 2.4% | $143.02 | +9.5% | COM | 759916109 |
| CNTX | CONTEXT THERAPEUTICS INC | 5,504,855 | $8.092M | 2.3% | $1.57 | -25.6% | COM | 21077P108 |
| MCK | MCKESSON CORP | 9,520 | $7.809M | 2.3% | $747.44 | +9.1% | COM | 58155Q103 |
| ICLR | ICON PLC | 33,100 | $6.031M | 1.7% | $178.08 | 0.0% | SHS | G4705A100 |
| A | AGILENT TECHNOLOGIES INC | 41,500 | $5.647M | 1.6% | $143.72 | 0.0% | COM | 00846U101 |
| PFE | PFIZER INC | 203,600 | $5.07M | 1.5% | $24.14 | +3.7% | COM | 717081103 |
| CNC | CENTENE CORP DEL | 119,400 | $4.913M | 1.4% | $37.43 | 0.0% | COM | 15135B101 |
| KVUE | KENVUE INC | 232,800 | $4.016M | 1.2% | $20.06 | -19.0% | COM | 49177J102 |
| DHR | DANAHER CORPORATION | 17,000 | $3.892M | 1.1% | $205.28 | +6.9% | COM | 235851102 |
| TMO | THERMO FISHER SCIENTIFIC INC | 6,700 | $3.882M | 1.1% | $475.70 | +18.8% | COM | 883556102 |
| NVO | NOVO-NORDISK A S | 67,300 | $3.424M | 1.0% | $50.88 | — | ADR | 670100205 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 206,076 | $3.419M | 1.0% | $16.93 | -15.6% | COM | 71722W107 |
| EHC | ENCOMPASS HEALTH CORP | 31,600 | $3.354M | 1.0% | $113.68 | +1.8% | COM | 29261A100 |
| CI | THE CIGNA GROUP | 11,600 | $3.193M | 0.9% | $293.19 | -4.8% | COM | 125523100 |
| COR | CENCORA INC | 9,400 | $3.175M | 0.9% | $249.56 | +36.5% | COM | 03073E105 |
| INSM | INSMED INC | 17,700 | $3.081M | 0.9% | $94.59 | +92.9% | COM PAR $.01 | 457669307 |
| WAT | WATERS CORP | 8,100 | $3.077M | 0.9% | $367.96 | 0.0% | COM | 941848103 |
| ACAD | ACADIA PHARMACEUTICALS INC | 106,900 | $2.855M | 0.8% | $23.65 | +1.0% | COM | 004225108 |
| GMAB | GENMAB A/S | 92,000 | $2.834M | 0.8% | $20.66 | — | SPONSORED ADS | 372303206 |
| NTRA | NATERA INC | 11,800 | $2.703M | 0.8% | $95.53 | +118.3% | COM | 632307104 |
| IMUX | IMMUNIC INC | 4,699,411 | $2.508M | 0.7% | $1.22 | -40.0% | COM | 4525EP101 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 169,000 | $2.398M | 0.7% | $18.92 | 0.0% | COM | 00404A109 |
| ITGR | INTEGER HLDGS CORP | 29,800 | $2.337M | 0.7% | $79.69 | 0.0% | COM | 45826H109 |
| ELVN | ENLIVEN THERAPEUTICS INC | 140,300 | $2.161M | 0.6% | $20.27 | -1.7% | COM | 29337E102 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 19,300 | $2.02M | 0.6% | $85.31 | 0.0% | COM | 697947109 |
| HQY | HEALTHEQUITY INC | 16,900 | $1.548M | 0.4% | $101.38 | -5.6% | COM | 42226A107 |
| SCYX | SCYNEXIS INC | 2,081,660 | $1.316M | 0.4% | $1.57 | -56.7% | COM NEW | 811292200 |
| IQV | IQVIA HLDGS INC | 4,400 | $992K | 0.3% | $217.58 | 0.0% | COM | 46266C105 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 134,566 | $990K | 0.3% | $8.54 | -28.4% | COM NEW | 48576U205 |
| CORT | CORCEPT THERAPEUTICS INC | 22,000 | $766K | 0.2% | $78.55 | 0.0% | COM | 218352102 |